暴露组探索:妙佑医疗国际(Mayo Clinic) 有关环境暴露对健康影响的研究
Mayo Clinic来自空气、食物、产品和水中的环境化学物质、污染物、微生物和微粒可能会蓄积在我们每个人的体内。这些有时有害的暴露物会与我们的基因发生相互作用,从而引发疾病。妙佑医疗国际个体化医学中心的研究人员正在研究终生环境暴露(称为暴露组),并评估对这些暴露产生的生物反应。
来自空气、食物、产品和水中的环境化学物质、污染物、微生物和微粒可能会蓄积在我们每个人的体内。这些有时有害的暴露物会与我们的基因发生相互作用,从而引发疾病。妙佑医疗国际个体化医学中心的研究人员正在研究终生环境暴露(称为暴露组),并评估对这些暴露产生的生物反应。
تحتوي أجسادنا على تراكمات سنوات طويلة من المواد الكيميائية والملوّثات والميكروبات والجسيمات المتواجدة في البيئة المحيطة به، والتي نتعرّض لها يومياً عبر الهواء الذي نتنشّقه والطعام الذي نتناوله والمنتجات التي نلمسها والماء الذي نشربه.
Dentro de cada uno de nosotros puede existir una acumulación de sustancias químicas y contaminantes del ambiente, de microbios y de partículas adquiridas del aire que respiramos, de los alimentos que comemos, de los productos que tocamos y del agua que bebemos.
Heart failure is a common and devastating disorder for which there is no cure. Many cardiomyopathies —conditions that make it difficult for the heart to pump blood such as dilated cardiomyopathy (DCM) and arrhythmogenic cardiomyopathy (ACM) — can lead to heart failure, but treatments for patients with heart failure do not take these distinct conditions into account.
Children’s Hospital of Philadelphia (CHOP) has helped launch a new computational platform that will harmonize pediatric cancer data, allowing researchers, pharmaceutical companies, and advocacy groups to accelerate the pace of drug development for pediatric cancer. With funding from the National Cancer Institute (NCI) via a subcontract with Leidos Biomedical Research, current operator of the NCI’s Frederick National Laboratory for Cancer Research, CHOP researchers have created the Molecular Targets Platform to facilitate pediatric research in response to the Research to Accelerate Cures and Equity (RACE) for Children Act, which requires companies to test cancer drugs in children that are used in adults when there is a shared molecular target.
After an injury or surgery, physical therapy often plays an essential role in recovery. It can also improve fitness and function for people dealing with chronic pain. Experts from Hospital for Special Surgery offer tips on what to look for in a PT facility.
Here are some of the latest articles that have been added to the Drug Resistance channel on Newswise, a free source for journalists.
PASS (Point-Assisted Spinal Sonography), an ultrasound-guided lumbar puncture device from Chula doctors and engineers, helps increase the precision and confidence in spinal tap procedures while reducing risks and pain for patients.
A new position paper from the American College of Physicians (ACP) offers guidance regarding ethical decision-making for the integration of precision medicine and genetic testing into internal medicine. ACP's advice is published in Annals of Internal Medicine.
Leaders with Vanderbilt University Medical Center announced plans today for construction of the largest expansion to date for Vanderbilt University Hospital (VUH). Through this project a new inpatient tower will be built atop an existing parking structure located between 21st Avenue South and Medical Center Drive.
At the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo, laboratory medicine experts will present the cutting-edge research and technology that is revolutionizing clinical testing and patient care.
A University of Minnesota Twin Cities team has developed a new tool to predict and customize the rate of DNA editing, paving the way for more personalized, efficient genetic and cell therapies for diseases such as diabetes and cancer.
The latest research news in Climate Science on Newswise.
Antisense oligonucleotides, or ASOs, are molecules that can be used to control protein levels in cells.
In Biomicrofluidics, scientists reveal their development of a new type of prosthetic using microfluidics-enabled soft robotics that promises to greatly reduce skin ulcerations and pain in patients who have had an amputation between the ankle and knee. They started with a recent device that uses pneumatic actuators and miniaturized the actuators by designing a microfluidic chip with 10 integrated pneumatic valves to control each actuator. The control box is small and light enough to be worn as part of the prosthesis.
The latest expert commentary and research on SCOTUS decisions, including the overturn of Roe v. Wade
MD Anderson and Turning Point Therapeutics announced a strategic research and development alliance to evaluate Turning Points investigational targeted therapies against ROS1, NTRK, MET and other cancer drivers.
A team of investigators from Texas Heart Institute, Texas Children’s Hospital and Baylor College of Medicine uncovered new insights into the mechanisms underlying the progression of congenital heart disease (CHD) ― a spectrum of heart defects that develop before birth and remain the leading cause of childhood death.
There is a long history of confusion and controversy regarding the use of polypropylene mesh materials for pelvic floor disorders in women, such as stress urinary incontinence (SUI) or pelvic organ prolapse (POP). So what option would specialist surgeons choose if they were to undergo these procedures themselves? That's the question asked in a survey study in Urology Practice®, an Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.